Neuronetics appoints Nir Naor as CFO and promotes Cory Anderson amid leadership changes.

Neuronetics announced the appointment of Nir Naor as Chief Financial Officer effective July 23, 2026, bringing over 20 years of finance and life sciences experience. Cory Anderson was promoted to Executive Vice President and General Manager of Greenbrook, reflecting the growth of the clinic network. Additionally, Andrew Macan will step down as Executive Vice President, Chief Legal Officer, and Corporate Secretary effective August 15, 2026. These leadership changes aim to strengthen Neuronetics' financial discipline and operational growth as the company expands access to its neurohealth therapies and clinic services.